Skip to content

iShares U.S. Healthcare ETF

IYHNYSE ArcaiSharesA

$77.60−0.21 (−0.27%)

At close: Nov 2, 2026, 4:00 PM ET

Intraday session: down, 79 prints from 77.81 to 77.60. Range 77.17 to 77.99. Use the arrow keys to read each point.77.2077.4078.0010 AM12 PM2 PM4 PM
Expense ratio
0.37%
Fund size
$4.64B
1Y total return
+29.4%
Yield · Last 12 months
1.03%
Holdings
102
Avg volume · 30D
788K sh
52W range
low $59.63high $79.06
Launched
Filings
SEC EDGAR

The ETF.net IYH Grade

Based on 5 of 6 pillars

A

Score 71 out of 100

Rank
5 of 25
Six-pillar profile for IYH. Scores out of 100: Cost 69, Risk 76, Mission not scored, Tradability 91, Holdings 35, Durability 85. Strongest: Tradability (91). Weakest: Holdings (35). Based on 5 of 6 pillars.

Score 71 of 100 falls in the A band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    B69 out of 100
    Rank 7 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A76 out of 100
    Rank 7 of 25
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    A91 out of 100
    Rank 2 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D35 out of 100
    Rank 21 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A85 out of 100
    Rank 4 of 25

Our read on IYH

ETF.net Research

In short

AHealthcare in one ticker from the class of 2000: roughly 100 drug, biotech and device names drawn from the Russell 1000, with index caps that stop any single giant from running the show.

Stated mandate

The fund is designed to follow a healthcare-sector equity index focused on U.S. companies, while providing diversified exposure to pharmaceuticals, biotechnology, and healthcare equipment.

Why people hold it

  • The index is a Russell 1000 subset covering large and mid caps, so the fund reaches past mega-cap pharma into smaller device and biotech issuers.sec.gov
  • Concentration has a documented ceiling: at each quarterly rebalance no single issuer tops 22.5%, and positions above 4.5% are capped at 45% combined.sec.gov
  • At 0.37% with no waiver in the mix, the fee sits below the healthcare category median, and the fund has traded since June 12, 2000.
  • A multi-billion-dollar, actively traded iShares sector fund that pays quarterly and holds the stocks outright rather than swapping for exposure.ishares.com

Worth knowing

  • Cheaper routes to the same sector exist: XLV charges 0.08% and VHT 0.09%, neither relying on a waiver, against 0.37% here.
  • One sector, one country. Regulation, patent cycles and drug pricing drive it, with no bonds or foreign names in the mix to soften the ride.
  • Even with the caps, about 100 stocks means a handful of large pharma and device makers shape most of the movement.sec.gov

IYH Performance

Launched Jun 12, 2000

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

IYH$12,942
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. IYH $12,942. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000$12,000$13,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for IYH. Periods over one year show the average yearly return.
PeriodIYH
Year to date+20.5%
1 month+8.7%
3 months+14.2%
1 year+29.4%
3 yearsper year+15.8%
5 yearsper year+7.4%
10 yearsper year+12.2%

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for IYH
YearReturn barIYH
2026 YTD+20.5%
2025+13.2%
2024+3.0%
2023+2.2%
2022−4.5%
2021+23.4%
2020+15.6%

IYH in the news

IYH Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
1.03%Last 12 months
Payout per share
$0.80Last 12 months
Last payment
$0.19 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 40 payments from 2017 to 2026 YTD. Mar 24, 2017 $0.09; Jun 27, 2017 $0.09; Sep 26, 2017 $0.10; Dec 19, 2017 $0.11; Mar 22, 2018 $0.10; Jun 26, 2018 $0.10; Sep 26, 2018 $0.10; Dec 17, 2018 $0.12; Dec 28, 2018 $0.29; Mar 20, 2019 $0.10; Jun 17, 2019 $0.11; Sep 24, 2019 $0.15; Dec 16, 2019 $0.13; Mar 25, 2020 $0.12; Jun 15, 2020 $0.12; Sep 23, 2020 $0.18; Dec 14, 2020 $0.15; Mar 25, 2021 $0.13; Jun 10, 2021 $0.11; Sep 24, 2021 $0.17; Dec 13, 2021 $0.16; Mar 24, 2022 $0.14; Jun 9, 2022 $0.12; Sep 26, 2022 $0.20; Dec 13, 2022 $0.16; Mar 23, 2023 $0.16; Jun 7, 2023 $0.11; Sep 26, 2023 $0.23; Dec 20, 2023 $0.18; Mar 21, 2024 $0.17; Jun 11, 2024 $0.13; Sep 25, 2024 $0.23; Dec 17, 2024 $0.20; Mar 18, 2025 $0.16; Jun 16, 2025 $0.17; Sep 16, 2025 $0.19; Dec 16, 2025 $0.25; Mar 17, 2026 $0.19; Jun 15, 2026 $0.16; Sep 15, 2026 $0.19. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 15, 2026Sep 18, 2026$0.19
Jun 15, 2026Jun 18, 2026$0.16
Mar 17, 2026Mar 20, 2026$0.19
Dec 16, 2025Dec 19, 2025$0.25
Sep 16, 2025Sep 19, 2025$0.19
Jun 16, 2025Jun 20, 2025$0.17
Mar 18, 2025Mar 21, 2025$0.16
Dec 17, 2024Dec 20, 2024$0.20
Sep 25, 2024Sep 30, 2024$0.23
Jun 11, 2024Jun 17, 2024$0.13
Mar 21, 2024Mar 27, 2024$0.17
Dec 20, 2023Dec 27, 2023$0.18

See all 107 payments⁠

$10,000 in IYH 10 years ago paid $2,225 in dividends.⁠

IYH Risk

How much the fund’s monthly returns vary, scaled to a year.
14.4%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.78
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−17.9%
Trough May 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.57
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

IYH Cost

Overpaying vs XLV, cheapest in Health Care (Broad)

$5,824

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • IYH 0.37%

    $7,513

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • IYH 0.37%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2K$4K$6K$8K051015202530IYH $7,513XLV $1,689

Year by year

YearIYHXLVOverpaying
10$670$147$523
20$2,590$575$2,015
30$7,513$1,689$5,824

Other funds in Health Care (Broad)